K 3.1, 2.1
|
|
4cnxA
|
Surface residue engineering of bovine carbonic anhydrase to an extreme halophilic enzyme for potential application in postcombustion co2 capture
|
K 3.1, 2.1
|
|
4zwxA
|
Engineered carbonic anhydrase ix mimic in complex with glucosyl sulfamate inhibitor
|
K 3.1, 2.1
|
|
4xfwA
|
Crystal structure of the monoclinic form of alpha-carbonic anhydrase from the human pathogen helicobacter pylori
|
K 3.1, 2.1
|
|
5ogoA
|
Crystal structure of chimeric carbonic anhydrase i with 3-(benzylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
|
K 3.1, 2.1
|
|
5wexA
|
Discovery of new selenoureido analogs of 4-(4-fluorophenylureido) benzenesulfonamides as carbonic anhydrase inhibitors
|
K 3.1, 2.1
|
|
2weoA
|
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors
|
K 3.1, 2.1
|
|
5fngA
|
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
|
K 3.1, 2.1
|
|
1bnvA
|
Carbonic anhydrase ii inhibitor
|
K 3.1, 2.1
|
|
3uyqA
|
Hca 3
|
K 3.1, 2.1
|
|
5fnkA
|
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
|
K 3.1, 2.1
|
|
5brwA
|
Catalytic improvement of an artificial metalloenzyme by computational design
|
K 3.1, 2.1
|
|
5llhA
|
Crystal structure of human carbonic anhydrase isozyme ii with 4-(1,3-benzothiazol-2-ylthio)-2,3,5,6-tetrafluorobenzenesulfonamide
|
K 3.1, 2.1
|
|
1z93A
|
Human carbonic anhydrase iii:structural and kinetic study of catalysis and proton transfer.
|
K 3.1, 2.1
|
|
4hewA
|
Activity enhancers of h64a variant of human carbonic anhydrase ii possess multiple binding sites within and around the enzyme structure
|
K 3.1, 2.1
|
|
5n0eA
|
Crystal structure of human carbonic anhydrase ii in complex with (s)-4-(6,7-dihydroxy-1-phenyl-3,4-tetrahydroisoquinoline-1h-2-carbonyl)benzenesulfonamide.
|
K 3.1, 2.1
|
|
4qefA
|
Human carbonic anhydrase ii v207i - cyanate inhibitor complex
|
K 3.1, 2.1
|
|
5amdA
|
Three dimensional structure of human carbonic anhydrase ii in complex with 2-((2-phenylethyl)sulfamoyl)-4-sulfamoylbenzoic acid
|
K 3.1, 2.1
|
|
3okuA
|
Human carbonic anhydrase ii in complex with 2-ethylestrone-3-o-sulfamate
|
K 3.1, 2.1
|
|
3tvnX
|
Human carbonic anhydrase ii proton transfer mutant
|
K 3.1, 2.1
|
|
5yuiA
|
Co2 release in human carbonic anhydrase ii crystals: reveal histidine 64 and solvent dynamics
|
K 3.1, 2.1
|
|
6g98A
|
Three dimensional structure of human carbonic anhydrase ix in complex with sulfonamide
|
K 3.1, 2.1
|
|
5dvxA
|
Crystal structure of the catalytic-domain of human carbonic anhydrase ix at 1.6 angstrom resolution
|
K 3.1, 2.1
|
|
5g0cA
|
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c
|
K 3.1, 2.1
|
|
5ty8A
|
Identification of a new zinc binding chemotype by fragment screening
|
K 3.1, 2.1
|
|
3s77B
|
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase
|
K 3.1, 2.1
|
|
5dslA
|
Structure of co2 released holo-form of human carbonic anhydrase ii with 10 min warming
|
K 3.1, 2.1
|
|
5dsmA
|
Structure of co2 released holo-form of human carbonic anhydrase ii with 25 min warming
|
K 3.1, 2.1
|
|
2hfxA
|
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii
|
K 3.1, 2.1
|
|
3ml2A
|
Human carbonic anhydsase ii in complex with an aryl sulfonamide inhibitor
|
K 3.1, 2.1
|
|
2nn1A
|
Structure of inhibitor binding to carbonic anhydrase i
|
K 3.1, 2.1
|
|
4q8xA
|
Crystal structure of 1-hydroxy-5-(trifluoromethyl)pyridine-2(1h)-thione bound to human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
3uynA
|
Hca 3
|
K 3.1, 2.1
|
|
5t71A
|
Human carboanhydrase f131c_c206s double mutant in complex with sa-2
|
K 3.1, 2.1
|
|
1lg6A
|
Crystal structure analysis of hca ii mutant t199p in complex with thiocyanate
|
K 3.1, 2.1
|
|
3dvcA
|
X-ray crystal structure of mutant n62t of human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
3oilA
|
Human carbonic anhydrase ii mutant a65s, n67q (ca ix mimic) bound by 2-ethylestradiol 3-o-sulfamate
|
K 3.1, 2.1
|
|
1ugbA
|
Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by gly (a65g)
|
K 3.1, 2.1
|
|
3l14A
|
Human carbonic anhydrase ii complexed with althiazide
|
K 3.1, 2.1
|
|
3p4vA
|
Human carbonic anhydrase ii in complex with (+)-xylariamide a
|
K 3.1, 2.1
|
|
1xpzA
|
Structure of human carbonic anhydrase ii with 4-[4-o-sulfamoylbenzyl)(4-cyanophenyl)amino]-4h-[1,2,4]-triazole
|
K 3.1, 2.1
|
|
3hktA
|
Human carbonic anhydrase ii in complex with alpha-d-glucopyranosyl-(1->4)-1-thio-beta-d-glucopyranosylsulfonamide
|
K 3.1, 2.1
|
|
3lxeA
|
Human carbonic anhydrase i in complex with topiramate
|
K 3.1, 2.1
|
|
3p55A
|
Human carbonic anhydrase ii in complex with p-(4-ferrocenyl-1h-1,2,3-triazol-1-yl)benzenesulfonamide
|
K 3.1, 2.1
|
|
3u45X
|
Human carbonic anhydrase ii v143a
|
K 3.1, 2.1
|
|
3u7cA
|
Crystal structure of the v143i mutant of human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
4zwyA
|
Human carbonic anhydrase ii in complex with a glucosyl sulfamate inhibitor
|
K 3.1, 2.1
|
|
3t83A
|
Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates
|
K 3.1, 2.1
|
|
4fikA
|
Human carbonic anhydrase ii h64a complexed with thioxolone hydrolysis products
|
K 3.1, 2.1
|
|
5ekjA
|
Human carbonic anhydrase ii complexed with a two-faced guest
|
K 3.1, 2.1
|
|
4jswA
|
Human carbonic anhydrase ii h94c
|
K 3.1, 2.1
|
|
5eoiA
|
Crystal structure of copper bound human carbonic anhydrase ii
|
K 3.1, 2.1
|
2
|
4zwiA
|
Surface lysine acetylated human carbonic anhydrase ii in complex with a sulfamate-based inhibitor
|
K 3.1, 2.1
|
|
5fl4A
|
Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-naphthalen-1-yl-1,2,3-triazol-4-yl)thiophene-2-sulfonamide
|
K 3.1, 2.1
|
|
5wgpA
|
Human carbonic anhydrase ix-mimic complexed with acek
|
K 3.1, 2.1
|
|
4q7sA
|
Crystal structure of 1-hydroxy-4-methylpyridine-2(1h)-thione bound to human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
6g9uA
|
Three dimensional structure of human carbonic anhydrase ix in complex with sulfonamide
|
K 3.1, 2.1
|
|
2iliA
|
Refine atomic structure of human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
3rldA
|
Crystal structure of the y7i mutant of human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
2x7tA
|
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors.
|
K 3.1, 2.1
|
|
3k34A
|
Human carbonic anhydrase ii with a sulfonamide inhibitor
|
K 3.1, 2.1
|
|
2nmxA
|
Structure of inhibitor binding to carbonic anhydrase i
|
K 3.1, 2.1
|
|
2osmA
|
Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study
|
K 3.1, 2.1
|
|
3rj7A
|
Human carbonic anhydrase ii complexed with its inhibitor rhenium(i)triscarbonyl-cyclopentadienyl-carboxy-4-aminomethylbenzene-sulfonamide
|
K 3.1, 2.1
|
|
3k2fA
|
Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma
|
K 3.1, 2.1
|
|
2wejA
|
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors
|
K 3.1, 2.1
|
|
4e3gA
|
Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
|
K 3.1, 2.1
|
|
4ruyA
|
Crystal structure of human carbonic anhydrase ii in complex with 4-propoxybenzenesulfonamide
|
K 3.1, 2.1
|
|
3n3jA
|
Crystal structure of human carbonic anhydrase ii in complex with a benzenesulfonamide inhibitor
|
K 3.1, 2.1
|
|
5thnA
|
Crystal structure of 2-hydroxycyclohepta-2,4,6-triene-1-thione bound to human carbonic anhydrase 2
|
K 3.1, 2.1
|
|
1bnmA
|
Carbonic anhydrase ii inhibitor
|
K 3.1, 2.1
|
|
1ugeA
|
Human carbonic anhydrase ii [hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by leu (a65l)
|
K 3.1, 2.1
|
|
1ccuA
|
Structure-assisted redesign of a protein-zinc binding site with femtomolar affinity
|
K 3.1, 2.1
|
|
2gehA
|
N-hydroxyurea, a versatile zinc binding function in the design of metalloenzyme inhibitors
|
K 3.1, 2.1
|
|
4ht0A
|
Crystal structure of human carbonic anhydrase isozyme ii with the inhibitor.
|
K 3.1, 2.1
|
|
3s8xA
|
Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(4-methyl-6-oxo-1,6-dihydro-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
|
K 3.1, 2.1
|
|
4pzhA
|
Crystal structure of human carbonic anhydrase isozyme ii with 2,3,5,6-tetrafluoro-4[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
|
K 3.1, 2.1
|
|
4qiyA
|
Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
|
K 3.1, 2.1
|
|
4qsaA
|
Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-4-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide
|
K 3.1, 2.1
|
|
3saxA
|
Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-5-{[(5-ethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
|
K 3.1, 2.1
|
|
4q6eA
|
Crystal structure of human carbonic anhydrase isozyme ii with 4-{[3-(3,5-dimethyl-1h-pyrazol-1-yl)-3-oxopropyl]amino}benzene-1-sulfonamide
|
K 3.1, 2.1
|
|
3n4bA
|
Crystal structure of human carbonic anhydrase ii in complex with a benzenesulfonamide inhibitor
|
K 3.1, 2.1
|
|
4kuwA
|
Crystal structure of human carbonic anhydrase ii in complex with the 5-(3-(4-fluorophenylsulfonyl)ureido)pyridine-2-sulfonamide inhibitor
|
K 3.1, 2.1
|
|
1xegA
|
Crystal structure of human carbonic anhydrase ii complexed with an acetate ion
|
K 3.1, 2.1
|
|
4knmA
|
Crystal structure of human carbonic anhydrase isozyme xiii with 2-chloro-4-{[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetyl}benzenesulfonamide
|
K 3.1, 2.1
|
|
2nwpA
|
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
1h4nA
|
H94n carbonic anhydrase ii complexed with tris
|
K 3.1, 2.1
|
|
6gotA
|
Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-(phenethylthio)benzenesulfonamide
|
K 3.1, 2.1
|
|
1g4jA
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,3,4,5,6-pentafluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
|
6fafA
|
Crystal structure of human carbonic anhydrase i in complex with the 3-(2,5-dimethylphenyl)-1-(2-hydroxy-5-sulfamoylphenyl)urea inhibitor
|
K 3.1, 2.1
|
|
3s73B
|
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase
|
K 3.1, 2.1
|
|
3pjjA
|
Synthetic dimer of human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
4e49A
|
Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
|
K 3.1, 2.1
|
|
5sz6A
|
Carbonic anhydrase ix-mimic in complex with 4-(3-formylphenyl)-benzenesulfonamide
|
K 3.1, 2.1
|
|
4rfcA
|
Human carbonic anhydrase ii in complex with tert-butyl 4-(4-sulfamoylphenoxy)butylcarbamate
|
K 3.1, 2.1
|
|
4kuvA
|
Crystal structure of human carbonic anhydrase ii in complex with the 5-(3-(4-chlorophenylsulfonyl)ureido)pyridine-2-sulfonamide inhibitor
|
K 3.1, 2.1
|
|
4l5uA
|
The structural implications of the secondary co2 binding pocket in human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
4hbaA
|
Structural and catalytic characterization of a thermal and acid stable variant of human carbonic anhydrase ii containing an engineered disulfide bond
|
K 3.1, 2.1
|
|
5n24A
|
Crystal structure of human carbonic anhydrase ii in complex with the inhibitor b4'-cyano-biphenyl-4-sulfonic acid amide
|
K 3.1, 2.1
|
|
4qjpA
|
Crystal structure of human carbonic anhydrase isozyme xiii with inhibitor
|
K 3.1, 2.1
|
|
3zp9A
|
Human carbonic anhydrase ii as a scaffold for an artificial transfer hydrogenase
|
K 3.1, 2.1
|
|
4qjoA
|
Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with inhibitor
|
K 3.1, 2.1
|
|
5l9eA
|
Crystal structure of human carbonic anhydrase ii in complex with a quinoline oligoamide foldamer
|
K 3.1, 2.1
|
|
4fvoA
|
Carbonic anhydrase ii in complex with n-[(2e)-3,4-dihydroquinazolin-2(1h)-ylidene]sulfuric diamide
|
K 3.1, 2.1
|
|
4lu3A
|
The crystal structure of the human carbonic anhydrase xiv
|
K 3.1, 2.1
|
|
4kv0A
|
Crystal structure of human carbonic anhydrase ii in complex with the 5-(3-tosylureido)pyridine-2-sulfonamide inhibitor
|
K 3.1, 2.1
|
|
4q99A
|
Crystal structure of 2-mercapto-4-methylphenol bound to human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
4q87A
|
Crystal structure of 1-hydroxy-4-(trifluoromethyl)pyridine-2(1h)-thione bound to human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
4fu5A
|
Carbonic anhydrase ii in complex with n-[(2z)-1,3-oxazolidin-2-ylidene]sulfuric diamide
|
K 3.1, 2.1
|
|
4q83A
|
Crystal structure of 1-hydroxy-3-(trifluoromethyl)pyridine-2(1h)-thione bound to human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
5yujA
|
Co2 release in human carbonic anhydrase ii crystals: reveal histidine 64 and solvent dynamics
|
K 3.1, 2.1
|
|
1kwqA
|
Human carbonic anhydrase ii complexed with inhibitor 2000-07
|
K 3.1, 2.1
|
|
1jd0A
|
Crystal structure of the extracellular domain of human carbonic anhydrase xii complexed with acetazolamide
|
K 3.1, 2.1
|
|
1g52A
|
Carbonic anhydrase ii complexed with 4-(aminosulfonyl)-n-[(2,3-difluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
|
1i90A
|
Carbonic anhydrase ii complexed with al-8520 2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-amino-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (r)
|
K 3.1, 2.1
|
|
2cbbA
|
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
|
K 3.1, 2.1
|
|
1i8zA
|
Carbonic anhydrase ii complexed with al-6629 2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 2-(3-methoxyphenyl)-3-(4-morpholinyl)-, 1,1-dioxide
|
K 3.1, 2.1
|
|
1v9eA
|
Crystal structure analysis of bovine carbonic anhydrase ii
|
K 3.1, 2.1
|
|
1g4oA
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-phenylmethylbenzamide
|
K 3.1, 2.1
|
|
2cbcA
|
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
|
K 3.1, 2.1
|
|
1i9oA
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,3,4-trifluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
|
1g1dA
|
Carbonic anhydrase ii complexed with 4-(aminosulfonyl)-n-[(2-fluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
2
|
2fouA
|
Human carbonic anhydrase ii complexed with two-prong inhibitors
|
K 3.1, 2.1
|
|
1if7A
|
Carbonic anhydrase ii complexed with (r)-n-(3-indol-1-yl-2-methyl-propyl)-4-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
1if9A
|
Carbonic anhydrase ii complexed with n-[2-(1h-indol-5-yl)-butyl]-4-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
1i91A
|
Carbonic anhydrase ii complexed with al-6619 2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 2-(3-hydroxyphenyl)-3-(4-morpholinyl)-, 1,1-dioxide
|
K 3.1, 2.1
|
|
2ez7A
|
Carbonic anhydrase activators. activation of isozymes i, ii, iv, va, vii and xiv with l- and d-histidine and crystallographic analysis of their adducts with isoform ii: engineering proton transfer processes within the active site of an enzyme
|
K 3.1, 2.1
|
|
1i9mA
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,4-difluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
|
1g0eA
|
Site-specific mutant (his64 replaced with ala) of human carbonic anhydrase ii complexed with 4-methylimidazole
|
K 3.1, 2.1
|
|
1i9pA
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,4,6-trifluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
|
1if8A
|
Carbonic anhydrase ii complexed with (s)-n-(3-indol-1-yl-2-methyl-propyl)-4-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
2fmgA
|
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine and crystallographic analysis of their adducts with isozyme ii: sterospecific recognition within the active site of an enzyme and its consequences for the drug design, structure with l-phenylalanine
|
K 3.1, 2.1
|
|
1thkA
|
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
|
K 3.1, 2.1
|
2
|
3eftA
|
Crystal structure of the complex between carbonic anhydrase ii and a spin-labeled sulfonamide incorporating tempo moiety
|
K 3.1, 2.1
|
|
3efiA
|
Carbonic anhydrase activators: kinetic and x-ray crystallographic study for the interaction of d- and l-tryptophan with the mammalian isoforms i-xiv
|
K 3.1, 2.1
|
|
3v5gA
|
Crystal structure of human carbonic anhydrase ii in complex with the 4-sulfamido-benzenesulfonamide inhibitor
|
K 3.1, 2.1
|
|
3dbuA
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
K 3.1, 2.1
|
|
3czvA
|
Crystal structure of the human carbonic anhydrase xiii in complex with acetazolamide
|
K 3.1, 2.1
|
|
2q1qA
|
Carbonic anhydrase inhibitors. interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and x-ray crystallographic studies
|
K 3.1, 2.1
|
|
4cnwA
|
Surface residue engineering of bovine carbonic anhydrase to an extreme halophilic enzyme for potential application in postcombustion co2 capture
|
K 3.1, 2.1
|
|
3bl0A
|
Carbonic anhydrase inhibitors. interaction of 2-n,n-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with twelve mammalian isoforms: kinetic and x-ray crystallographic studies
|
K 3.1, 2.1
|
|
2wegA
|
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors
|
K 3.1, 2.1
|
|
3sbiA
|
Crystal structure of human carbonic anhydrase isozyme ii with 4-[(2-pyrimidinylsulfanyl)acetyl]benzenesulfonamide
|
K 3.1, 2.1
|
|
3d0nA
|
Crystal structure of human carbonic anhydrase xiii
|
K 3.1, 2.1
|
|
6h29A
|
Human carbonic anhydrase ii in complex with benzyl carbamate
|
K 3.1, 2.1
|
|
1canA
|
Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions
|
K 3.1, 2.1
|
|
5gmnA
|
Crystal structure of human carbonic anhydrase ii in complex with polmacoxib
|
K 3.1, 2.1
|
|
2ax2A
|
Production and x-ray crystallographic analysis of fully deuterated human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
5dskA
|
Structure of co2 released holo-form of human carbonic anhydrase ii with 3 min warming
|
K 3.1, 2.1
|
|
5ljtA
|
Crystal structure of human carbonic anhydrase ii in complex with the 4-((1-phenyl-1h-1,2,3-triazol-4-yl)methoxy)benzenesulfonamide inhibitor
|
K 3.1, 2.1
|
|
2abeA
|
Carbonic anhydrase activators: x-ray crystal structure of the adduct of human isozyme ii with l-histidine as a platform for the design of stronger activators
|